Abstract
In the present study, we evaluated the ability of GPI-anchored mucin-like glycoproteins purified from Trypanosoma cruzi trypomastigotes (tGPI-mucin) to trigger phosphorylation of different mitogen-activated protein kinases (MAPKs) and related transcription factors in inflammatory macrophages. Kinetic experiments show that the peak of extracellular signal-related kinase (ERK)-1/ERK-2, stress-activated protein kinase (SAPK) kinase-1/mitogen-activated protein kinase (MAPK) kinase-4, and p38/SAPK-2, phosphorylation occurs between 15 and 30 min after macrophage stimulation with tGPI-mucin or GPI anchors highly purified from tGPI-mucins (tGPI). The use of the specific inhibitors of ERK-1/ERK-2 (PD 98059) and p38/SAPK-2 (SB 203580) phosphorylation also indicates the role of MAPKs, with possible involvement of cAMP response element binding protein, in triggering TNF-alpha and IL-12 synthesis by IFN-gamma-primed-macrophages exposed to tGPI or tGPI-mucin. In addition, tGPI-mucin and tGPI were able to induce phosphorylation of I kappa B, and the use of SN50 peptide, an inhibitor of NF-kappa B translocation, resulted in 70% of TNF-alpha synthesis by macrophages exposed to tGPI-mucin. Finally, the similarity of patterns of MAPK and I kappa B phosphorylation, the concentration of drugs required to inhibit cytokine synthesis, as well as cross-tolerization exhibited by macrophages exposed to tGPI, tGPI-mucin, or bacterial LPS, suggest that receptors with the same functional properties are triggered by these different microbial glycoconjugates.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Activating Transcription Factor 2
-
Animals
-
Cyclic AMP Response Element-Binding Protein / metabolism
-
Cytokines / biosynthesis*
-
Enzyme Activation / drug effects
-
Enzyme Activation / immunology
-
Enzyme Inhibitors / pharmacology
-
Flavonoids / pharmacology
-
Glycosylphosphatidylinositols / metabolism*
-
I-kappa B Proteins / metabolism*
-
Imidazoles / pharmacology
-
Immune Tolerance / drug effects
-
Inflammation / immunology
-
Interleukin-12 / biosynthesis
-
Lipopolysaccharides / immunology
-
Lipopolysaccharides / pharmacology*
-
MAP Kinase Kinase 4*
-
Macrophage Activation / drug effects
-
Macrophages / drug effects
-
Macrophages / enzymology*
-
Macrophages / immunology
-
Macrophages / metabolism
-
Mice
-
Mice, Inbred C3H
-
Mice, Inbred C57BL
-
Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Mitogen-Activated Protein Kinase 8
-
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase Kinases / metabolism
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / metabolism*
-
Mucins / immunology
-
NF-kappa B / physiology
-
Nitric Oxide / biosynthesis
-
Phosphorylation / drug effects
-
Protozoan Proteins / immunology
-
Pyridines / pharmacology
-
Receptors, Cell Surface / physiology*
-
Transcription Factors / metabolism
-
Trypanosoma cruzi / immunology*
-
Tumor Necrosis Factor-alpha / biosynthesis
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Activating Transcription Factor 2
-
Cyclic AMP Response Element-Binding Protein
-
Cytokines
-
Enzyme Inhibitors
-
Flavonoids
-
Glycosylphosphatidylinositols
-
I-kappa B Proteins
-
Imidazoles
-
Lipopolysaccharides
-
Mucins
-
NF-kappa B
-
Protozoan Proteins
-
Pyridines
-
Receptors, Cell Surface
-
TgPI protein, Toxoplasma gondii
-
Transcription Factors
-
Tumor Necrosis Factor-alpha
-
glycolipid receptor
-
Interleukin-12
-
Nitric Oxide
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 8
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
MAP Kinase Kinase 4
-
Map2k4 protein, mouse
-
Mitogen-Activated Protein Kinase Kinases
-
SB 203580
-
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one